Figure 3 — The efficacy of immune checkpoint inhibitors is limited in elderly NSCLC: a retrospective efficacy study and meta-analysis

Research Paper|Volume 15, Issue 24|pp. 15025–15049

The efficacy of immune checkpoint inhibitors is limited in elderly NSCLC: a retrospective efficacy study and meta-analysis

Back to articleFigure 3(3 of 4)

100%

Figure 3.Forest plots of overall survival of NSCLC patients < 75 years and ≥ 75 years by age. CI, confidence interval; ICIs, immune checkpoint inhibitors.